FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/08/2026
Back to search
Official data from USPTO
AFFIBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079374502Class
1, 5, 10, 42, 44
Filing
79374502
Registration
7805540
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 10, 42, 44
Filing date
03/31/2023
Registration date
05/27/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SE
Examiner
SWIFT, GILBERT M
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the black wording, "AFFIBODY" at right; the blue design of three solid circles over a solid, curved band appears at left; the color white represents background, outlining, shading and/or transparent areas and is not part of the mark.
Holders and representatives
Holders
Affibody AB
Representatives
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical substances and materials for industrialscientific and laboratory use other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary purposesbiochemical preparations for scientific purposes; biochemical substances for scientific purposes; chemical substances for use in the production of drugspharmaceuticals and antibodies; reagents for scientificlaboratoryanalysisresearchmedical researchtestinginspectiondetecting or verification use other than for medical or veterinary purposes; reagents for use in the development of antibodies other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis other than for medical or veterinary purposes; antibodies and antibodies-based chemicalsexcept for medical or veterinary use
Class 5
Medical and veterinary substancespreparations and articlesMedical diagnostic reagents and assays for testing of bodily fluidsClinical diagnostic reagents for medical useDiagnostic biomarker reagents for medical purposesDiagnostic reagents and agents for medical diagnostic useDiagnostic reagents for clinical laboratory useReagents for use in medical genetic testingRadiopharmaceutical imaging and detection agents for diagnosing and monitoring cancercontrast media for use with imaging medical equipment; pharmaceutical preparations and substancesbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of neoplasmscancer diseasesinflammatory eyeskinmuscle and joint diseases and disordersdiseases and disorders of the immune systemautoimmune diseases and disorderslocal and systemic bacterial infectionsviral infectionsfungal infectionscentral nervous system (CNS) diseasescirculatory systemrespiratory systemrespiratory diseases and disorderscardiovascular diseasesrenal diseasesliver diseasesskin diseasesdiseases of the digestive systemgastro-intestinal diseaseseye diseases and conditionsdiseases of the musculoskeletal system or connective tissue; pharmaceutical preparations and substancesbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of diseases and disorders of the peripheral nervous systemnamely cranial and spinal neuropathiesautonomic neuropathiessensorimotor neuropathies and plexopathiesdiseases of the blood or blood forming organs; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of disorders of the lymphatic systems namely LymphangitisLymphocytosisMesenteric lymphadenitis; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of metabolic diseases namely obesitydiabetesmetabolic syndromeinborn errors of metabolismhypoglycaemiagoutosteoarthritismuscular dystrophyanemia; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of diseases of the endocrine systemnamely glucose homeostasis disordersthyroid disorderscalcium homeostasis disorders and metabolic bone diseasepituitary gland disorderssex hormone disorders and tumours of the endocrine glands; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for use in ophthalmology; pharmaceutical preparationsbiochemical preparationsbiological preparationsantibodies and antibodies-based pharmaceutical preparations for the treatment of diseases of the genitourinary systemnamely prostatereproductive and urological diseases and disorders; diagnostic preparations and materials for medical purposes; medical therapeutic agents for regulation of biological functionsprotein inhibition or activationweight control and appetite suppression; reagents for medicalsurgicalveterinary and dental use; biochemical biomarkers for medical use; diagnostic biomarker reagents for medical purposes; sanitary preparations for medical purposes
Class 10
Medical and veterinary apparatus and instrumentsmedical apparatus and instruments for use in surgerychromatography media in the nature of liquid chromatography apparatus for medical use in medical research; diagnosticexaminationmonitoring equipment namelymedical apparatus and instruments for diagnostic radiopharmaceutical use; screening apparatus and instruments for medical purposesultrasonic medical diagnostic apparatus; separation instruments for medical usetubing and valve assembly set and electromechanical fluidic instrumentother similar or related deviceswhich process human whole blood for the purpose of separating human blood components for use in blood transfusions and washing human red blood cells with clinical medical reagents for use in blood transfusions chromatography columns for use in affinity separationchromatography media for use in affinity separation; gas chromatographic instruments for medical use; diagnostic imaging apparatus for medical use; medication fluid injectors
Class 42
Scientific researchtechnological researchproduct development and design in the field of biotechnics and diagnostics; medical and pharmacological research services for medical purposes in the field of biotechnics and diagnostics; medicalpharmaceutical and biotechnological laboratory research services for medical purposes in the field of biotechnics and diagnostics; scientific investigations for medical purposes; medical and scientific researchconducting clinical trials for others; providing scientific information about the results of clinical trials for pharmaceutical products; scientific advisory services relating to diagnostic preparations; biochemical analysis and research for medical purposes in the field of biotechnics and diagnostics; drug discovery services; pharmaceutical products development and evaluation
Class 44
Human healthcare services; medical services; providing medical information; physical examination; medical diagnostic testingmonitoring and reporting services; optical medical imaging for medical diagnostic use; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
38 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/22/2025
FIMP
FINAL DISPOSITION PROCESSED
12/22/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/27/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/27/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2025
PUBO
PUBLISHED FOR OPPOSITION
04/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/13/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/13/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/13/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/13/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/04/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/18/2024
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
09/16/2024
GNSF
SUBSEQUENT FINAL EMAILED
09/16/2024
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
09/16/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/11/2024
GNFR
FINAL REFUSAL E-MAILED
09/11/2024
CNFR
FINAL REFUSAL WRITTEN
09/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2024
RFNT
REFUSAL PROCESSED BY IB
01/31/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2024
RFRR
REFUSAL PROCESSED BY MPU
01/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/29/2023
CNRT
NON-FINAL ACTION WRITTEN
12/28/2023
DOCK
ASSIGNED TO EXAMINER
12/27/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/20/2023
Continuous trademark protection
Get notified about every new filing that threatens AFFIBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.